#ada2019 search results
Best of ADA 2019. Atractivo programa científico para compartir con algunos ponentes de la #ADA2019 los aspectos más destacados. @SEDiabetes
The moment has arrived! 🏆 We've finally revealed the 100 entries that have conquered a spot on the podium of the 4th edition of the #ArchiproductsDesignAwards. Discover now the 2019 winners! ☞ bit.ly/ADA2019winners #ADA2019
Paravan Mood, design Lievore Altherr, has been awarded over 700 product applications from 400 international brands with the @Archiproducts #ADA2019. More at: bit.ly/33NaJUo #ArperAwards
LA LINEA by @BIGstertweets was awarded at 2019 @archiproducts DESIGN AWARD! A pure, uninterrupted light trail, App compatible, for any application in any environmental condition. More on Archiproducts ► bit.ly/2qwSaVp #archiproducts #archiproductsdesignawards #ADA2019
Otra lección del #carolina #ADA2019 #2019ADA quizas tendremos que replantearnos si las hipoglucemias van ligadas a afectacion vascular @SociedadSeedo @sociedadSEEN
DYK? The Official Highlights of #ADA2019 includes research summaries, faculty interviews, & slide kits from this year's largest #diabetes meeting. View it now: bit.ly/333eJ2X
Now available: the Official Highlights of #ADA2019. Access the highlights to review clinical insights & research discussed at this year’s meeting, view interviews w/ faculty, & more: bit.ly/333eJ2X
#NikolaTesla Flame wins 🏆 the #ArchiproductsDesignAward, which celebrates excellence in international design. Super proud! #ADA2019 #Elicarianuova #Elica
Thanks to everyone who attended #ADA2019. View our Facebook photo album for some of the meeting's highlights: bit.ly/2WVBJl3
“An incredible journey…a guide for anyone similarly challenged by #diabetes.” John J. Kelly, Detroit Free Press, Five Stars @AmDiabetesAssn #ADA2019 @aBookPublicist amzn.to/2xfZlSe
In a landmark clinical trial, anti-CD3 delayed the onset of type 1 diabetes - the first time the disease has been markedly delayed in young people at high risk. Two weeks of the experimental intravenous (IV) drug held off the disease.bit.ly/2wMnv6I #ADA2019 @T1D_Trialnet
"Research” is the keyword for #StudioMilo when it comes to define good design ☞ bit.ly/2Mi9RAB #TalkingToJurors #ADA2019
Teplizumab Lives! 10 Reasons to Buy $PRVB Up to Almost Any Price? #ADA2019 $LLY $MGNX #Type1diabetes #TrialNet disruptivetr.com/2019/06/09/tep…
What expectations do #ADA2019 attendees and experts have for Teplizumab @T1D_TrialNet results being presented? #diabetes professional.diabetes.org/scientific-ses…
Great meeting my old friend since 1998, #EdJude, last time was #ADA2019 - immediately sparked 2 data-based projects on the #DiabeticFoot and #CharcotFoot - and loads of ideas and good laughs. Only at #ADA2022. - @TGCCG @AalborgUH #SDCN #StenoNord @Reg_Nord @AmDiabetesAssn #DFSG
Great meeting prof Frank Snoek at #ADA2022 - met last #ADA2019 - then and now heavily into discussing #PersonCentred #DiabetesCare and #ValueBasedHealthcare -It is all about individual treatment, taking PWD needs and wishes into account. @AmDiabetesAssn #SDCN #StenoNord @Reg_Nord
2 years ago...to the day? San Francisco #ADA2019 @_RomanHovorka said to @drpratikc @WilmotEmma @LalanthaL and me... "Let me show you something over breakfast" It was @CAMSAPS_FX - the world's 1st #ArtificalPancreas App And a promise was made 2 years later? We keep the promise
What you eat affects your heart, blood vessels, and blood glucose. Watch LIVE 12 pm CDT as @Chef_Ronaldo shows how to cook yummy heart-healthy, diabetes-friendly recipes. Nutrition experts from @AmDiabetesAssn @American_Heart answer questions. #ADA2019 spr.ly/ipy6
El año pasado en #ADA2019 👉 Teplizumab demostró tener capacidad de reducir la aparición de DT1 hasta por dos año. Este año en #ADA2020 👉 Resultados actualizados demuestran retraso de hasta 3 años 👀👇 es.beyondtype1.org/teplizumab-act…
Last year at #ADA2019 👉 Teplizumab was shown to be able to significantly delay—for over 2 years—the onset of T1D. This year at #ADA2020 👉 Updated results showed that the delay was closer to 3 years, + half of those treated remain diabetes-free! 👀👇 beyondtype1.org/teplizumab-upd…
beyondtype1.org
Preventing and Delaying Type 1 Diabetes: Updates From the Teplizumab Trial | Beyond Type 1
Half of those treated with teplizumab remain diabetes-free, compared to 22% of those taking placebo, and the delay in diabetes onset was close to 3 years.
・リベルサス．経口のGLP-1受容体作動薬． 経口GLP-1受容体作動薬のリベルサス（セマグルチド）が日本でも承認．皮下注射は海外にて高い効果が報告されているが，日本では発売が遅れていた． #ADA2019 にて発表されてたPIONEER 4 Trialでは経口のほうがデータがよい可能性． thelancet.com/journals/lance…
It has been exactly a year since this work was presented #ADA2019; Project mentored @medmum3 & supported @UHL_ClinEd @LDC_tweets😊#PatientSafety #InsulinSafety A parallel & a popular session at the time #TheLegend @kamleshkhunti😁What a diff 🌍we live in now🦠✈️⛔️#ADAGoesVirtual
13/ The future is even more promising! During the #ADA2019 meeting, #EliLilly demonstrated that its dual-incretin-agonist tirzepatide (GIP/GLP-1 RA) is even more potent than pure GLP-1 RA. A1c ⬇️~1.9% and Wt ⬇️up to 25 lbs!
Tirzepatide. This is a name we are going to hear so much more about. The name for @LillyDiabetes Dual GIP/GLP-1 RA. All post-hoc data from thelancet.com/journals/lance… Points towards marked ⬆️ in Liver health. N.B. ⬇️HbA1c by 1.89% ⬇️wt 11.3kg in the top dose (15mg). #ADA2019
¡Excelente! Una pregunta clave: ¿Cómo hacen que sus pacientes entiendan la importancia de la pérdida de peso? Asimismo, les comparto la cobertura del Dr. @GotesJose de DiRECT de #ADA2019 espanol.medscape.com/verarticulo/59…
Drs. Magee & Hamdy have finished their talks to Day 2 session & hence to the 1st #BestofADAEgypt20 official program. Great level of attendance & interaction. Excellent discussions. Thanks to both local organizers & faculty. @AmDiabetesAssn @ADA_DiabetesPro #ADA2019 #diabetes
One of our favourite launches of 2019 - Lume by Marazzi - has won the Best Design Product award in the 'Finishes' category at the @Archiproducts Design Awards! #ADA2019 Read about the winning tile over on our blog: tilesandmosaics.co.uk/latest-news/an…
As 2019 draws to a close, we look back on Ada's top blogs/news stories of the yr. It's been an incredible year for Ada, and we are super proud of everything our staff & students have achieved. Take another look at our 2018/19 progression report: ow.ly/rFJ450xF3e6 #Ada2019
Market Brief: Abbott, Dexcom Help Drive Continuous Glucose Monitoring Market; 30% Expected Growth by 2023 #diabetes #ada2019 medtech.pharmaintelligence.informa.com/articles/2019/…
As we enter the final days of the year, we're looking back at Ada's top blogs/news stories of 2019. October and November saw our first open evenings of the term: ow.ly/nlIE50xF2Oo If you'd like to visit Ada check out our website: ada.ac.uk/sixth-form/boo… #Ada2019
As we enter the final week of the year, we're looking back at Ada's top blogs/news stories of 2019. Back in October, Ada welcomed our new chair of the board @tiffanymhall! Revisit our blog to find out more: ow.ly/s6kJ50xF1fp #Ada2019
Reducción del 51% (sign) en Mortalidad Cardiovascular en #Sustain6 Espectacular 👏🏻👏🏻👏🏻 @DrTinahones @estebanjodar @DiegoBellido2 @ValleAlfonso @almucastro01 @domingomarzal @DrDoblas #ADA2019
Ya esta !!!! REWIND Dulaglutide reduce MACE 12 % a expensas de disminuir Ictus un 24 % #ADA2019 #2019ADA
LA LINEA by @BIGstertweets was awarded at 2019 @archiproducts DESIGN AWARD! A pure, uninterrupted light trail, App compatible, for any application in any environmental condition. More on Archiproducts ► bit.ly/2qwSaVp #archiproducts #archiproductsdesignawards #ADA2019
Por primera vez en el mundo se presentan datos combinados Sustain6+Pioneer6 👏🏻👏🏻👏🏻 MACE 🔽 0,76 (0,72-0,92) #ada2019
#ProfesionalDeLaSalud te queremos poner al tanto del Congreso #ADA2019 @AmDiabetesAssn #FMDNoticias Investigadores encuentran tasas aceleradas de complicaciones graves en adultos jóvenes con Diabetes tipo 2 de inicio en la juventud. Continúa leyendo: bit.ly/2IntQvU
Go Raptors! With the Canadians (and some Americans- sorry!) @JimJohnsonSci @bwicklow1 @chrisadoucette @BruceVerchere @GLim2016 @spaeth_jason @ADA_Journals #ADA2019
Guidelines address CGM goals for #T1D + #T2D, older/high-risk patients, and pregnant women with diabetes. ms.spr.ly/6018TK5EO #ADA2019
DYK? The Official Highlights of #ADA2019 includes research summaries, faculty interviews, & slide kits from this year's largest #diabetes meeting. View it now: bit.ly/333eJ2X
#ArchiproductsMilano will be the setting for the evening dedicated to winning brands and designers. On November 14th, winners will receive the trophy designed by @mutdesign and realized by #DeCastelli ☞bit.ly/2O60UvJ #ADA2019
#ProfesionalDeLaSalud esto te puede interesar. Te queremos poner al tanto del Congreso #ADA2019 @AmDiabetesAssn #FMDNoticias La dapagliflozina reduce la progresión de la enfermedad renal y la muerte renal en personas con Diabetes tipo 2. Continúa leyendo: bit.ly/2WQFLLl
#ADA2019 #BestofAdaSpain19 Diabetic Neuropathy: A Position Statement by the American Diabetes Association Rodica Pop-Busui et al . Diabetes Care 2017 care.diabetesjournals.org/content/40/1/1… @risingstarsgdps @SemergenGTDM @SEDiabetes
nejm.org/doi/full/10.10… Oral Semaglutide and Cardiovascular Outcomes in Patients with Type 2 Diabetes @NEJM presentado en #ADA2019 @DrTinahones @estebanjodar @almucastro01
Something went wrong.
Something went wrong.
United States Trends
- 1. The AI-generated N/A
- 2. BLACKPINK N/A
- 3. #TheTraitorsUS N/A
- 4. Lakers N/A
- 5. Maura N/A
- 6. #ResidentEvilRequiem N/A
- 7. Bruno Mars N/A
- 8. #Scream7 N/A
- 9. Jisoo N/A
- 10. Paramount N/A
- 11. Luka N/A
- 12. Ayton N/A
- 13. Marathon N/A
- 14. Pakistan N/A
- 15. $Jellybean N/A
- 16. #TheRomantic N/A
- 17. Walkman N/A
- 18. Labour N/A
- 19. Suns N/A
- 20. Reaves N/A